100 related articles for article (PubMed ID: 1918801)
1. Preparation of unaltered hemoglobin from human placentas for possible use in blood substitutes.
Fasan G; Grandgeorge M; Vigneron C; Dellacherie E
J Biochem Biophys Methods; 1991; 23(1):53-66. PubMed ID: 1918801
[TBL] [Abstract][Full Text] [Related]
2. Large scale preparation of functional human placental hemoglobin for use in blood substitutes.
Fasan G; Vigneron C; Dellacherie E; Grandgeorge M
Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):489-91. PubMed ID: 1391468
[No Abstract] [Full Text] [Related]
3. Purification and chemical modifications of hemoglobin in developing hemoglobin based oxygen carriers.
Haney CR; Buehler PW; Gulati A
Adv Drug Deliv Rev; 2000 Feb; 40(3):153-69. PubMed ID: 10837787
[TBL] [Abstract][Full Text] [Related]
4. Separation and determination of reduced vitamin C in polymerized hemoglobin-based oxygen carriers of the human placenta.
Chen G; Mo L; Li S; Zhou W; Wang H; Liu J; Yang C
Artif Cells Nanomed Biotechnol; 2015 Jun; 43(3):152-6. PubMed ID: 25420754
[TBL] [Abstract][Full Text] [Related]
5. Purification and viral inactivation of hemoglobin from human placenta blood.
Li F; Zhang H; Wang J; Yang C
Artif Cells Blood Substit Immobil Biotechnol; 2009; 37(2):57-60. PubMed ID: 19229697
[TBL] [Abstract][Full Text] [Related]
6. A PEGylated bovine hemoglobin as a potent hemoglobin-based oxygen carrier.
Wang Y; Wang L; Yu W; Gao D; You G; Li P; Zhang S; Zhang J; Hu T; Zhao L; Zhou H
Biotechnol Prog; 2017 Jan; 33(1):252-260. PubMed ID: 27696787
[TBL] [Abstract][Full Text] [Related]
7. DBBF modified human placenta hemoglobin through the alpha chains.
Huang L; Wang B; Wang X; Liang WG; Yang CM
Artif Cells Blood Substit Immobil Biotechnol; 2008; 36(2):156-65. PubMed ID: 18437592
[TBL] [Abstract][Full Text] [Related]
8. A convenient method for the determination of the solubility of hemoglobin and modified hemoglobins.
Anderson PJ; Biro GP
Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(3):753-61. PubMed ID: 7994398
[TBL] [Abstract][Full Text] [Related]
9. Novel water-mediated hydrogen bonds as the structural basis for the low oxygen affinity of the blood substitute candidate rHb(alpha 96Val-->Trp).
Puius YA; Zou M; Ho NT; Ho C; Almo SC
Biochemistry; 1998 Jun; 37(26):9258-65. PubMed ID: 9649306
[TBL] [Abstract][Full Text] [Related]
10. Blood substitutes.
Palmer AF; Intaglietta M
Annu Rev Biomed Eng; 2014 Jul; 16():77-101. PubMed ID: 24819476
[TBL] [Abstract][Full Text] [Related]
11. The proton Bohr factor of native and crosslinker treated hemoglobins--its possible significance for the efficacy of hemoglobin based artificial oxygen carriers.
Barnikol WK
Adv Exp Med Biol; 1994; 361():363-70. PubMed ID: 7597959
[TBL] [Abstract][Full Text] [Related]
12. Random chemical modification of hemoglobin to identify chloride binding sites in the central dyad axis: their role in control of oxygen affinity.
Manning JM
Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(2):199-205. PubMed ID: 8087242
[TBL] [Abstract][Full Text] [Related]
13. A potential blood substitute from carboxylic dextran and oxyhemoglobin. I. Preparation, purification and characterization.
Prouchayret F; Fasan G; Grandgeorge M; Vigneron C; Menu P; Dellacherie E
Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):319-22. PubMed ID: 1382641
[TBL] [Abstract][Full Text] [Related]
14. Effect of Cl- and H+ on the oxygen binding properties of glutaraldehyde-polymerized bovine hemoglobin-based blood substitutes.
Eike JH; Palmer AF
Biotechnol Prog; 2004; 20(5):1543-9. PubMed ID: 15458341
[TBL] [Abstract][Full Text] [Related]
15. Removal of Arg141 from the alpha chain of human hemoglobin by carboxypeptidases N and M.
Michel B; Igić R; Leray V; Deddish PA; Erdös EG
Circ Res; 1996 Apr; 78(4):635-42. PubMed ID: 8635221
[TBL] [Abstract][Full Text] [Related]
16. Antioxidant effects of vitamin C on hemoglobin-based oxygen carriers derived from human cord blood.
Chen G; Duan Y; Liu J; Wang H; Yang C
Artif Cells Nanomed Biotechnol; 2016; 44(1):56-61. PubMed ID: 26671172
[TBL] [Abstract][Full Text] [Related]
17. [Comparative study of chemically modified hemoglobins as a basis for oxygen-carrying blood substitutes].
Azhigirova MA; Viazova EP; Shuvalova AL; Vashkevich MG
Biull Eksp Biol Med; 1993 Apr; 115(4):364-6. PubMed ID: 8049393
[TBL] [Abstract][Full Text] [Related]
18. Structural and functional properties of human hemoglobins reassembled after synthesis in Escherichia coli.
Hui HL; Kavanaugh JS; Doyle ML; Wierzba A; Rogers PH; Arnone A; Holt JM; Ackers GK; Noble RW
Biochemistry; 1999 Jan; 38(3):1040-9. PubMed ID: 9894000
[TBL] [Abstract][Full Text] [Related]
19. An optimal polymerization process for low mean molecular weight HBOC with lower dimer.
Zhou W; Li S; Hao S; Liu J; Wang H; Yang C
Artif Cells Nanomed Biotechnol; 2015 Jun; 43(3):148-51. PubMed ID: 25519745
[TBL] [Abstract][Full Text] [Related]
20. Polymerized human placenta hemoglobin improves resuscitative efficacy of hydroxyethyl starch in a rat model of hemorrhagic shock.
Li Y; Yan D; Hao S; Li S; Zhou W; Wang H; Liu J; Wang X; Yang C
Artif Cells Nanomed Biotechnol; 2015 Jun; 43(3):174-9. PubMed ID: 25812000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
